Novel Tripeptides as Tyrosinase Inhibitors: In Silico and In Vitro Approaches
2024

New Tripeptides as Tyrosinase Inhibitors

publication 10 minutes Evidence: moderate

Author Information

Author(s): Dymek Michał, Warszycki Dawid, Podlewska Sabina, Sikora Elżbieta

Primary Institution: Cracow University of Technology

Hypothesis

Can novel tripeptides effectively inhibit tyrosinase activity?

Conclusion

The developed tripeptides are non-toxic and effective tyrosinase inhibitors, potentially useful in cosmetic products.

Supporting Evidence

  • The CSF peptide showed the lowest IC50 value of 136.04 µM.
  • All tripeptides demonstrated tyrosinase inhibition.
  • The peptides were confirmed to be non-toxic to human skin cells.
  • Molecular dynamics simulations showed stable interactions with tyrosinase.
  • The CSF peptide had the highest copper chelating activity.

Takeaway

Scientists created new tiny proteins that can stop a skin pigment from forming, which can help with skin brightening.

Methodology

Molecular modeling and in vitro assays were used to develop and test the tripeptides for tyrosinase inhibition.

Limitations

The study did not explore the long-term effects of the tripeptides on human skin.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.3390/ijms252413509

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication